290 related articles for article (PubMed ID: 35488312)
1. Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses.
Zuo B; Zhang Y; Zhao K; Wu L; Qi H; Yang R; Gao X; Geng M; Wu Y; Jing R; Zhou Q; Seow Y; Yin H
J Hematol Oncol; 2022 Apr; 15(1):46. PubMed ID: 35488312
[TBL] [Abstract][Full Text] [Related]
2. Dendritic cell-derived exosomes elicit tumor regression in autochthonous hepatocellular carcinoma mouse models.
Lu Z; Zuo B; Jing R; Gao X; Rao Q; Liu Z; Qi H; Guo H; Yin H
J Hepatol; 2017 Oct; 67(4):739-748. PubMed ID: 28549917
[TBL] [Abstract][Full Text] [Related]
3. Alarmin augments the antitumor immunity of lentiviral vaccine in ectopic, orthotopic and autochthonous hepatocellular carcinoma mice.
Liu Z; Lu Z; Jing R; Zuo B; Gao X; Han G; Qi H; Wu L; Liu Y; Yin H
Theranostics; 2019; 9(14):4006-4018. PubMed ID: 31281528
[TBL] [Abstract][Full Text] [Related]
4. Alarmin-painted exosomes elicit persistent antitumor immunity in large established tumors in mice.
Zuo B; Qi H; Lu Z; Chen L; Sun B; Yang R; Zhang Y; Liu Z; Gao X; You A; Wu L; Jing R; Zhou Q; Yin H
Nat Commun; 2020 Apr; 11(1):1790. PubMed ID: 32286296
[TBL] [Abstract][Full Text] [Related]
5. Epitope-optimized alpha-fetoprotein genetic vaccines prevent carcinogen-induced murine autochthonous hepatocellular carcinoma.
Hong Y; Peng Y; Guo ZS; Guevara-Patino J; Pang J; Butterfield LH; Mivechi NF; Munn DH; Bartlett DL; He Y
Hepatology; 2014 Apr; 59(4):1448-58. PubMed ID: 24122861
[TBL] [Abstract][Full Text] [Related]
6. Caveolin-mediated cytosolic delivery of spike nanoparticle enhances antitumor immunity of neoantigen vaccine for hepatocellular carcinoma.
Lin Z; Jiang C; Wang P; Chen Q; Wang B; Fu X; Liang Y; Zhang D; Zeng Y; Liu X
Theranostics; 2023; 13(12):4166-4181. PubMed ID: 37554274
[No Abstract] [Full Text] [Related]
7. Tumor-derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humans in vitro.
Rao Q; Zuo B; Lu Z; Gao X; You A; Wu C; Du Z; Yin H
Hepatology; 2016 Aug; 64(2):456-72. PubMed ID: 26990897
[TBL] [Abstract][Full Text] [Related]
8. Complete remission of tumors in mice with neoantigen-painted exosomes and anti-PD-1 therapy.
Zhang Y; Zuo B; Yu Z; Zhao K; Zhang Y; He K; Seow Y; Yin H
Mol Ther; 2023 Dec; 31(12):3579-3593. PubMed ID: 37919900
[TBL] [Abstract][Full Text] [Related]
9. Association Between High-Avidity T-Cell Receptors, Induced by α-Fetoprotein-Derived Peptides, and Anti-Tumor Effects in Patients With Hepatocellular Carcinoma.
Nakagawa H; Mizukoshi E; Kobayashi E; Tamai T; Hamana H; Ozawa T; Kishi H; Kitahara M; Yamashita T; Arai K; Terashima T; Iida N; Fushimi K; Muraguchi A; Kaneko S
Gastroenterology; 2017 May; 152(6):1395-1406.e10. PubMed ID: 28188748
[TBL] [Abstract][Full Text] [Related]
10. Identification of α-fetoprotein-specific T-cell receptors for hepatocellular carcinoma immunotherapy.
Zhu W; Peng Y; Wang L; Hong Y; Jiang X; Li Q; Liu H; Huang L; Wu J; Celis E; Merchen T; Kruse E; He Y
Hepatology; 2018 Aug; 68(2):574-589. PubMed ID: 29443377
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapeutic strategies for hepatocellular carcinoma.
Butterfield LH
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S232-41. PubMed ID: 15508089
[TBL] [Abstract][Full Text] [Related]
12. Personalized neoantigen vaccine combined with PD-1 blockade increases CD8
Chen H; Li Z; Qiu L; Dong X; Chen G; Shi Y; Cai L; Liu W; Ye H; Zhou Y; Ouyang J; Cai Z; Liu X
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36113894
[TBL] [Abstract][Full Text] [Related]
13. Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells.
Yang JY; Cao DY; Xue Y; Yu ZC; Liu WC
Hum Immunol; 2010 Mar; 71(3):255-62. PubMed ID: 20036295
[TBL] [Abstract][Full Text] [Related]
14. Regulatory T Cell Inhibition by P60 Combined with Adenoviral AFP Transduced Dendritic Cells for Immunotherapy of Hepatocellular Carcinoma.
Sadeghlar F; Seelemann J; Vogt A; Möhring C; Zhou T; Mahn R; Kornek M; Lukacs-Kornek V; Casares N; Lasarte JJ; Sarobe P; van Beekum C; Matthaei H; Manekeller S; Kalff J; Schmidt-Wolf IGH; Strassburg CP; Gonzalez-Carmona MA
Immunol Invest; 2023 Nov; 52(8):966-984. PubMed ID: 37846958
[TBL] [Abstract][Full Text] [Related]
15. Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer.
Huang L; Rong Y; Tang X; Yi K; Qi P; Hou J; Liu W; He Y; Gao X; Yuan C; Wang F
Mol Cancer; 2022 Feb; 21(1):45. PubMed ID: 35148751
[TBL] [Abstract][Full Text] [Related]
16. Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells.
González-Carmona MA; Märten A; Hoffmann P; Schneider C; Sievers E; Schmidt-Wolf IG; Sauerbruch T; Caselmann WH
Liver Int; 2006 Apr; 26(3):369-79. PubMed ID: 16584401
[TBL] [Abstract][Full Text] [Related]
17. A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma.
Palmer DH; Midgley RS; Mirza N; Torr EE; Ahmed F; Steele JC; Steven NM; Kerr DJ; Young LS; Adams DH
Hepatology; 2009 Jan; 49(1):124-32. PubMed ID: 18980227
[TBL] [Abstract][Full Text] [Related]
18. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy of hepatocellular carcinoma with a vaccine based on xenogeneic homologous alpha fetoprotein in mice.
Zhang W; Liu J; Wu Y; Xiao F; Wang Y; Wang R; Yang H; Wang G; Yang J; Deng H; Li J; Wen Y; Wei Y
Biochem Biophys Res Commun; 2008 Nov; 376(1):10-4. PubMed ID: 18725206
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapeutic strategies for treatment of hepatocellular carcinoma with antigen-loaded dendritic cells: in vivo study.
El-Ashmawy NE; El-Zamarany EA; Khedr EG; El-Bahrawy HA; El-Feky OA
Clin Exp Med; 2018 Nov; 18(4):535-546. PubMed ID: 30062618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
